Health Ministry: No shortage of HCQ tablets in country

New Delhi: The health minitry has ensured that there is no shortage of hydroxychloroquine tablets (HCQ) in the country at present as well as in the future, accordinh to Union Health Ministry Joint Secretary Lav Aggarwal.

“It is ensured that not only today even in future there will not be any lack of HCQ (hydroxychloroquine) as and when needed,” Aggarwal said.

Earlier, Temporary licensed was granted by the India for the export of paracetamol and anti-malarial drug hydroxychloroquine (HCQ) in appropriate quantities to some countries, which have been badly affected by the coronavirus pandemic.

According to the Indian Council of Medical Research (ICMR), “hydroxychloroquine is recommended only to those asymptomatic healthcare workers involved in the care of suspected or confirmed cases of COVID-19 and asymptomatic household contacts of laboratory-confirmed cases.”

“5,194 positive confirmed cases have been reported and 402 people have been discharged so far. Over the last 24 hours, 773 positive cases have been reported. A total of 149 deaths have been reported. As many as 32 people died yesterday,” Agarwal said.

  • Related Posts

    ‘Import of Refurbished Medical Devices’ Lobby has reared its Ugly Head

    Domestic Medical Device Leaders cry foul against move to do away with Policy Restrictions New Delhi:  The union government mandarins seem to be at it again, diametrically opposed to Prime…

    Indigenous Robotic Surgery is Mantra for Accessible Cancer Care in India

    Best in Class ‘Made in India’ Surgical Robot is proving Best Bet New Delhi: ‘Made in India’ best in class surgical robot SSiMantra is proving godsend for cancer patients in…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Diabetic drug metformin found to act on brain

    Diabetic drug metformin found to act on brain

    Hetero debuts semaglutide generic in emerging markets

    Hetero debuts semaglutide generic in emerging markets

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework